Wearable nerve-stimulation therapy devices for chronic neurological conditions
Cala Health builds wearable peripheral nerve stimulation therapies, starting with essential tremor. Its stack spans embedded firmware on ARM Cortex-M chips, React Native mobile apps, and Brightree for DME billing, meaning it runs device engineering, software and reimbursement operations in-house. Accelerating hiring targets QA automation, security programs and manufacturing transfer for the Cala kIQ device, pointing to a new product moving toward FDA clearance and scale.
Cala Health is a privately held bioelectronic medicine company founded in 2014 and headquartered in San Mateo, California. It develops wearable neuromodulation devices that deliver individualized peripheral nerve stimulation, with essential tremor as its first indication and further programs in neurology, cardiology and psychiatry. The company employs 51–200 people and hires in the United States. Its operations cover hardware design, companion software, manufacturing, clinical training for healthcare providers, and durable medical equipment distribution.
Cala Health uses C++ on ARM Cortex-M0/M3/M4 for device firmware, React, React Native and TypeScript for apps, FastAPI and Python on the backend, PostgreSQL, MySQL, DynamoDB and MongoDB, plus SolidWorks, NetSuite, Salesforce and Brightree.
Current work centers on developing the Cala kIQ device and transferring it to manufacturing, building automated regression and AI-assisted test generation, launching a penetration testing program, and clinical training for providers.
Cala Health is headquartered in San Mateo, California, in the San Francisco Bay Area, and hires in the United States. It has 51–200 employees and was founded in 2014.
Other companies in the same industry, closest in size
Cala Health's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.